Journal
CELL CYCLE
Volume 8, Issue 19, Pages 3112-3119Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.8.19.9626
Keywords
DNA damage; signaling; cell cycle checkpoints; synthetic lethality; MAPKAP kinase-2; ATM; Chk2
Categories
Funding
- NIH [GM68762, CA112967, ES015339]
- NIH Integrative Cancer Biology Program [U54-CA112967-03]
- Deutsche Forschungsgemeinschaft [RE2246/1-1]
- Deutsche Nierenstiftung
- David H. Koch Fund
Ask authors/readers for more resources
Emerging data suggests that synthetic lethal interactions between mutated oncogenes/tumor suppressor genes and molecules involved in DNA damage signaling and repair can be therapeutically exploited to preferentially kill tumor cells. In this review, we discuss the concept of synthetic lethality, and describe several recent examples in which this concept was successfully implemented to target tumor cells in culture, in mouse models, and in human cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available